SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Concord Drugs - Quaterly Results

13 Feb 2024 Evaluate
The sales is pegged at Rs. 126.24 millions for the December 2023 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 135.27 millions during the year-ago period.The Net Loss for the quarter ended December 2023 is Rs. -2.39 millions as compared to Net Profit of Rs. 4.54 millions of corresponding quarter ended December 2022The company reported a degrowth in operating Profit to 5.62 millions from 14.45 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 126.24 135.27 -6.68 288.02 397.82 -27.60 513.23 590.57 -13.10
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 5.62 14.45 -61.11 34.97 36.13 -3.21 43.52 56.94 -23.57
Interest 4.32 4.49 -3.79 12.12 12.07 0.41 16.25 16.81 -3.33
PBDT 1.30 9.96 -86.95 22.85 24.06 -5.03 27.27 40.13 -32.05
Depreciation 3.85 3.80 1.32 11.48 12.96 -11.42 16.03 17.65 -9.18
PBT -2.55 6.16 -141.40 11.37 11.10 2.43 11.24 22.48 -50.00
TAX -0.16 1.62 -109.88 3.63 2.86 26.92 2.33 6.54 -64.37
Deferred Tax -0.11 -0.05 120.00 -0.54 -0.38 42.11 -1.14 -0.18 533.33
PAT -2.39 4.54 -152.64 7.74 8.24 -6.07 8.91 15.94 -44.10
Equity 100.00 87.44 14.36 100.00 87.44 14.36 93.16 87.44 6.54
PBIDTM(%) 4.45 10.68 -58.33 12.14 9.08 33.69 8.48 9.64 -12.05

Concord Drugs Share Price

81.90 4.27 (5.50%)
15-Apr-2026 12:36 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1683.50
Dr. Reddys Lab 1218.45
Cipla 1224.50
Zydus Lifesciences 935.20
Lupin 2350.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×